Literature DB >> 22535988

Comparison of dimethyl sulfoxide and water as solvents for echinocandin susceptibility testing by the EUCAST methodology.

Ana Alastruey-Izquierdo1, Alicia Gómez-López, Maiken C Arendrup, Cornelia Lass-Florl, William W Hope, David S Perlin, Juan L Rodriguez-Tudela, Manuel Cuenca-Estrella.   

Abstract

Ninety-six strains of Candida, including 29 resistant and 67 susceptible isolates with mutations in the FKS1 and FKS2 genes were tested by the European Committee on Antibiotic Susceptibility Testing EDef 7.1 and 7.2 methodologies to determine the impact on the MIC when water was replaced with dimethyl sulfoxide (DMSO) as the solvent for caspofungin and micafungin. The MICs were significantly lower and the MIC ranges were narrower when DMSO was used as the solvent. The use of DMSO may help to better discriminate between susceptible and resistant populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535988      PMCID: PMC3405639          DOI: 10.1128/JCM.00791-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.

Authors:  M A Pfaller; M Castanheira; S R Lockhart; A M Ahlquist; S A Messer; R N Jones
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

2.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

3.  EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).

Authors:  Maiken C Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William Hope
Journal:  Clin Microbiol Infect       Date:  2012-05-08       Impact factor: 8.067

Review 4.  Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Authors:  M A Pfaller; D J Diekema; D Andes; M C Arendrup; S D Brown; S R Lockhart; M Motyl; D S Perlin
Journal:  Drug Resist Updat       Date:  2011-02-24       Impact factor: 18.500

5.  Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.

Authors:  Mariana Castanheira; Leah N Woosley; Daniel J Diekema; Shawn A Messer; Ronald N Jones; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

6.  Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.

Authors:  Maiken Cavling Arendrup; Juan-Luis Rodriguez-Tudela; Steven Park; Guillermo Garcia-Effron; Guillaume Delmas; Manuel Cuenca-Estrella; Alicia Gomez-Lopez; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

Review 7.  Current perspectives on echinocandin class drugs.

Authors:  David S Perlin
Journal:  Future Microbiol       Date:  2011-04       Impact factor: 3.165

8.  Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005.

Authors:  Guy St-Germain; Michel Laverdière; René Pelletier; Pierre René; Anne-Marie Bourgault; Claude Lemieux; Michael Libman
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

9.  Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.

Authors:  Maiken Cavling Arendrup; Guillermo Garcia-Effron; Walter Buzina; Klaus Leth Mortensen; Nanna Reiter; Christian Lundin; Henrik Elvang Jensen; Cornelia Lass-Flörl; David S Perlin; Brita Bruun
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

10.  Acquired resistance to echinocandins in Candida albicans: case report and review.

Authors:  Marie-Thérèse Baixench; Naji Aoun; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne; Sandrine Ramires; Christophe Piketty; Eric Dannaoui
Journal:  J Antimicrob Chemother       Date:  2007-04-27       Impact factor: 5.790

View more
  9 in total

1.  Comparison of MICs of fluconazole and flucytosine when dissolved in dimethyl sulfoxide or water.

Authors:  Annette W Fothergill; Carmita Sanders; Nathan P Wiederhold
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

2.  Cyrene™ is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens.

Authors:  Jason E Camp; Simbarashe B Nyamini; Fraser J Scott
Journal:  RSC Med Chem       Date:  2019-12-17

3.  Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance.

Authors:  Ryan K Shields; M Hong Nguyen; Ellen G Press; Cassaundra L Updike; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

4.  In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.

Authors:  Fabiola Fernández-Silva; Michaela Lackner; Javier Capilla; Emilio Mayayo; Deanna Sutton; Mariana Castanheira; Annette W Fothergill; Cornelia Lass-Flörl; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

5.  Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.

Authors:  Ryan K Shields; M Hong Nguyen; Ellen G Press; Cassaundra L Updike; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

6.  Pterostilbene complexed with cyclodextrin exerts antimicrobial and anti-inflammatory effects.

Authors:  Yi Rong Ivan Lim; Philip M Preshaw; Lum Peng Lim; Marianne Meng Ann Ong; Hai-Shu Lin; Kai Soo Tan
Journal:  Sci Rep       Date:  2020-06-03       Impact factor: 4.379

7.  Antimicrobial Activity of Different Artemisia Essential Oil Formulations.

Authors:  Sourav Das; Barbara Vörös-Horváth; Tímea Bencsik; Giuseppe Micalizzi; Luigi Mondello; Györgyi Horváth; Tamás Kőszegi; Aleksandar Széchenyi
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

8.  Antimicrobial Activity of Chamomile Essential Oil: Effect of Different Formulations.

Authors:  Sourav Das; Barbara Horváth; Silvija Šafranko; Stela Jokić; Aleksandar Széchenyi; Tamás Kőszegi
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

Review 9.  Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.

Authors:  Derry K Mercer; Marcelo D T Torres; Searle S Duay; Emma Lovie; Laura Simpson; Maren von Köckritz-Blickwede; Cesar de la Fuente-Nunez; Deborah A O'Neil; Alfredo M Angeles-Boza
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.